Drug Trial Radar · NCT01894958
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
Last checked: Nov 19, 2026Latest source record: Feb 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
72
Actual
Start
Jan 2014
Primary completion
Sep 2015
Study completion Oct 2015
Sponsor
- Lead sponsor
- Neuren Pharmaceuticals LimitedIndustry
- Sponsor type
- Industry
- First posted
- Jul 10, 2013
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Male only, from 12 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether NNZ-2566 is safe and well tolerated in the treatment of Fragile X Syndrome in adolescent and adult males.
Conditions
- Fragile X Syndrome
Interventions
NNZ-2566Drug
Glycyl-L-2-Methylpropyl-L-Glutamic Acid (NNZ-2566) supplied as a lyophilized powder (2g in 50mL vials or 3g in 30mL bottles) for reconstitution with strawberry flavored solution 0.5% v/v in Water for Injection.
PlaceboDrug
Strawberry flavored solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse eventsTime frame: Through to Day 56
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
UC Davis MIND Institute
Sacramento, California
Children's Hospital Colorado
Denver, Colorado
Children's National Hospital
Washington D.C., District of Columbia
Emory University
Atlanta, Georgia
Rush University Medical Center
Chicago, Illinois
Kennedy Krieger Institute
Baltimore, Maryland
University of Massachusetts Medical School
Worcester, Massachusetts
University of Michigan
Ann Arbor, Michigan
University of Nebraska
Omaha, Nebraska
Mount Sinai School of Medicine
New York, New York
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Autism & Developmental Medicine Institute Geisinger Health System
Lewisburg, Pennsylvania
Suburban Research Associates
Media, Pennsylvania
Greenwood Genetic Center
Greenwood, South Carolina
Vanderbilt University Medical Center
Nashville, Tennessee
Texas Children's Hospital
Houston, Texas
Seattle Children's Hospital
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.